Insights On Enterprise Solutions

  1. Design Scalable Downstream Processes With Practical Strategies 5/11/2026

    Downstream purification is becoming more complex as new modalities enter development. Learn how advanced analytics and chromatography strategies can support scalable, confident process development.

  2. Why Life Cycle Integration Is Critical To ADC And XDC Success 5/8/2026

    The ADC industry is expanding to supply targeted treatments to support unmet need and patient demand. To succeed, ADC developers must account for the manufacturing complexity of these molecules.

  3. From Insights To Impact: Predictive Models And PAT For More Efficient And Robust Biologics Manufacturing 5/8/2026

    Explore how advanced scale-up methodologies and real-time analytical technologies strengthen both drug substance and drug product manufacturing by enabling process understanding and informed decision-making.

  4. The Confidence To Go Faster: A Playbook For Digital Lab Operations 5/8/2026

    Bridge the gap between lab speed and scientific confidence. Learn to eliminate operational bottlenecks, ensure material readiness, and create the traceable data needed for an AI-ready future.

  5. Removing Cost Barriers To Scalable AAV Manufacturing 5/7/2026

    Alternative AAV manufacturing approaches can dramatically reduce cost per dose, improve scalability, and increase yields across serotypes, enabling broader patient access to gene therapies.

  6. Improving LVV And AAV Yield Through Cargo Gene Silencing 5/7/2026

    Silencing cargo gene expression during LVV and AAV production improves cell health, reduces impurities, and significantly increases vector yield for cytotoxic and difficult‑to‑manufacture transgenes.

  7. How Dermal Delivery Platforms Are Transforming Tomorrows For Patients 5/7/2026

    Skin delivery platforms expand therapies by boosting convenience, stability, and adherence. Integrated formulation, device, and manufacturing development is key to confidently scale.

  8. Early Developability Assessment For Antibody Based Therapeutics 5/7/2026

    Learn how an integrated developability and immunosafety toolbox can help de-risk multi-specific antibody development, improve candidate selection, and accelerate complex biologics toward the clinic.

  9. Precision Polymorph Screening With Electron Diffraction 5/6/2026

    See how polymorph screening with electron diffraction uncovers hidden forms, enabling precise identification and reliable quantification of minor phases affecting performance and manufacturability.

  10. De-Risking Drug Development: Informatics-Supported Solid Form Selection 5/6/2026

    Learn how combining polymorph screening with structural informatics improves solid‑form selection, lowers development risk, and boosts confidence in long‑term stability and manufacturability.